Cardiovascular risk and inflammation in a population with autoimmune diseases: a narrative review

C Bertoni, A Mazzocchi, L Leone, C Agostoni… - Frontiers in …, 2024 - frontiersin.org
Juvenile Systemic Connective Tissue Diseases (JSCTD) are a heterogeneous group of
chronic autoimmune diseases, associated with dyslipidemia and increased cardiovascular …

Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome

FI Corona-Meraz, M Vázquez-Del Mercado… - Journal of Clinical …, 2024 - mdpi.com
Metabolic syndrome (MetS) is a group of physiological abnormalities characterized by
obesity, insulin resistance (IR), and hypertriglyceridemia, which carry the risk of developing …

APOB and CCL17 as Mediators in the Protective Effect of SGLT2 Inhibition against Myocardial Infarction: Insights from Proteome-wide Mendelian Randomization

L Shi, G Li, N Hou, L Tu, J Li, J Luo, S Hu - European Journal of …, 2024 - Elsevier
Aims Sodium-glucose cotransporter 2 (SGLT2) inhibitors offer a novel therapeutic avenue
for myocardial infarction (MI). However, the exact nature of this relationship and the …

Hormone and reproductive factors and risk of systemic lupus erythematosus: a Mendelian randomized study

R Chang, S Xiang, Y Jin, X Xu, S Qian, L Chen… - Immunologic …, 2024 - Springer
Systemic lupus erythematosus (SLE) is an autoimmune and inflammatory disease with a risk
associated with hormonal and reproductive factors. However, the potential causal effects …

Association between the atherogenic index of plasma and bone mineral density among adult women: NHANES (2011–2018)

Q He, B Chen, F Liang, Z Zhang - Frontiers in Endocrinology, 2024 - frontiersin.org
Background Studies on the relationship between the atherogenic index of plasma (AIP) and
bone mineral density (BMD) among adult women in the United States are limited. The …

Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study

D Liang, S Huang, R Ding - Clinical Rheumatology, 2024 - Springer
This study is asked to investigate the effects of belimumab on the lipid profile in systemic
lupus erythematosus (SLE) patients. Forty-one SLE patients who received at least 6 months …

Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE

S Ferrigno, P Conigliaro, S Rizza, S Longo… - Lupus Science & …, 2023 - lupus.bmj.com
Objectives Patients with SLE have higher cardiovascular (CV) risk compared with healthy
controls (HC) and are characterised by accelerated atherosclerosis; intima media thickness …

Dyslipidemia is not associated with interferon-regulated chemokines or disease activity in systemic lupus erythematosus

L Hernández-Solano, E Amezcua-Castillo… - Clinical …, 2023 - Springer
Dear Editor, Emerging evidence is unraveling interdependent pathways connecting
dysregulated lipid handling with systemic inflammation, positioning dyslipidemia as a …

[HTML][HTML] Evaluation of lipid profile in systemic lupus erythematosus and relation with interleukin-10

S Verma, R Nanda, S Shah, J Meher, V Rathore… - Journal of Laboratory … - jlabphy.org
Objectives: To detect pattern of dyslipidemia in patients of SLE and clarify the correlation
between lipid profile with disease activity, inflammatory factors, and cytokines. Materials and …

Perfil metabolómico y espectroscópico urinario asociado a daño renal en una cohorte de pacientes colombianos con lupus eritematoso sistémico

AL Carmona Martes - 2023 - bonga.unisimon.edu.co
El lupus Eritematosos sistémico (LES) es una enfermedad de carácter autoinmune, crónica,
multifactorial que puede afectar y ocasionar daño a cualquier órgano del cuerpo entre ellos …